Companies: 10,638     total market cap: โ‚ฌ116.357 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Neurocrine Biosciences
NBIX
#1366
Rank
โ‚ฌ13.31 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
133,57ย โ‚ฌ
Share price
0.84%
Change (1 day)
10.13%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ0.95 Billion

According to Neurocrine Biosciences 's latest financial reports the company has โ‚ฌ0.95 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neurocrine Biosciences - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ1.03 B10.81%
2023-12-31โ‚ฌ0.93 B1.18%
2022-12-31โ‚ฌ0.92 B46.84%
2021-12-31โ‚ฌ0.62 B-3.55%
2020-12-31โ‚ฌ0.65 B8.8%
2019-12-31โ‚ฌ0.59 B5.19%
2018-12-31โ‚ฌ0.56 B32.32%
2017-12-31โ‚ฌ0.42 B47.16%
2016-12-31โ‚ฌ0.29 B-15.74%
2015-12-31โ‚ฌ0.34 B117.63%
2014-12-31โ‚ฌ0.15 B51%
2013-12-31โ‚ฌ0.10 B-19.32%
2012-12-31โ‚ฌ0.13 B31.57%
2011-12-31โ‚ฌ99.41 M4.23%
2010-12-31โ‚ฌ95.37 M155.59%
2009-12-31โ‚ฌ37.31 M-35.17%
2008-12-31โ‚ฌ57.56 M-53.15%
2007-12-31โ‚ฌ0.12 B-11.22%
2006-12-31โ‚ฌ0.13 B-39.97%
2005-12-31โ‚ฌ0.23 B3.84%
2004-12-31โ‚ฌ0.22 B-38.33%
2003-12-31โ‚ฌ0.35 B53.76%
2002-12-31โ‚ฌ0.23 B-35.39%
2001-12-31โ‚ฌ0.36 B107.28%
2000-12-31โ‚ฌ0.17 B93.08%
1999-12-31โ‚ฌ90.53 M818.22%
1998-12-31โ‚ฌ9.85 M-25.95%
1997-12-31โ‚ฌ13.31 M39.82%
1996-12-31โ‚ฌ9.52 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Repligen
RGEN
โ‚ฌ0.64 B-32.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚ฌ1.55 B 62.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
โ‚ฌ2.16 M-99.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ8.51 B 789.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ4.87 B 408.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ12.86 B 1,244.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚ฌ0.23 B-75.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ0.87 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com